The mechanisms of how glutamine benefits critically ill patients have not been established. The purpose of this study was to determine the effects of dietary and endogenously produced glutamine on small intestinal morphology using light and transmission electron microscopy in artificially reared rat pups. It was hypothesized that deprivation of dietary glutamine leads to intestinal disease that is exacerbated by inhibition of glutamine synthetase by methionine sulfoximine (MS). Rat pups were placed into five different test groups: The first was a reference group that was reared by their mother. The other four groups were reared artificially and received a 10% Travasol amino acid solution at 5 g/kg per day, which does not contain glutamine, added to a mixture containing carbohydrates, lipids, and vitamins. This dose was chosen because it represents an approximation of the amount of glutamine these rats would be receiving in a normal rat diet (approximately 40 g/kg per day total protein, 10 to 15% of which is glutamine ϩ glutamate). The glutamine was manipulated by adding glutamine (Q) or MS or both. The four groups were as follows: MSϪQϪ, MSϪQϩ, MSϩQϪ, and MSϩQϩ. Light microscopy revealed the greatest blunting of villus height in the ileum of rats from the MSϩQϪ group when compared with the MSϪQϩ group (123 Ϯ 48.9 m versus 207 Ϯ 36 m, p Ͻ 0.05). The other two groups exhibited intermediate villus heights, but all were shorter than the villi from the mother-reared animals. The number of villi per unit length of bowel was also lowest in the animals that were treated with MS and not provided with dietary glutamine. Transmission electron microscopy demonstrated breakdown of the epithelial junctions in the glutamine-deprived and glutamine synthetase-inhibited intestines. Glutamine-deprived animals also displayed sloughing of microvilli, decreased actin cores, and degeneration of the terminal web. In summary, these studies support the hypothesis that glutamine is involved with maintenance of intestinal epithelial integrity. Previous studies have found that glutamine supplementation significantly decreases morbidity among critically ill patients. Adult bone marrow transplant recipients who received glutamine i.v. had significant decreases in length of hospital stay, hospital-acquired sepsis, and hospital costs (1, 2). Studies in VLBW infants found that glutamine supplementation resulted in decreased morbidity and hospital costs (3-5). Additionally, studies in rodents found that glutamine supplementation provides protection against sepsis and subsequent distal organ damage (6, 7). The mechanisms of how glutamine acts to promote these beneficial effects are not known. However, there is evidence that its effect on intestinal mucosal integrity may play a role. The addition of glutamine to TPN has been demonstrated to maintain the integrity of small intestinal mucosa, therefore, preventing the atrophy typically noted with TPN (8). In a previous study of multiple animal species, administration of glutaminase decreased plasma glutamine levels to almost undetectable levels (9). This resulted in mild villous atrophy, mucosal ulcerations, and intestinal necrosis.
The mechanisms of how glutamine benefits critically ill patients have not been established. The purpose of this study was to determine the effects of dietary and endogenously produced glutamine on small intestinal morphology using light and transmission electron microscopy in artificially reared rat pups. It was hypothesized that deprivation of dietary glutamine leads to intestinal disease that is exacerbated by inhibition of glutamine synthetase by methionine sulfoximine (MS). Rat pups were placed into five different test groups: The first was a reference group that was reared by their mother. The other four groups were reared artificially and received a 10% Travasol amino acid solution at 5 g/kg per day, which does not contain glutamine, added to a mixture containing carbohydrates, lipids, and vitamins. This dose was chosen because it represents an approximation of the amount of glutamine these rats would be receiving in a normal rat diet (approximately 40 g/kg per day total protein, 10 to 15% of which is glutamine ϩ glutamate). The glutamine was manipulated by adding glutamine (Q) or MS or both. The four groups were as follows: MSϪQϪ, MSϪQϩ, MSϩQϪ, and MSϩQϩ. Light microscopy revealed the greatest blunting of villus height in the ileum of rats from the MSϩQϪ group when compared with the MSϪQϩ group (123 Ϯ 48.9 m versus 207 Ϯ 36 m, p Ͻ 0.05). The other two groups exhibited intermediate villus heights, but all were shorter than the villi from the mother-reared animals. The number of villi per unit length of bowel was also lowest in the animals that were treated with MS and not provided with dietary glutamine. Transmission electron microscopy demonstrated breakdown of the epithelial junctions in the glutamine-deprived and glutamine synthetase-inhibited intestines. Glutamine-deprived animals also displayed sloughing of microvilli, decreased actin cores, and degeneration of the terminal web. In summary, these studies support the hypothesis that glutamine is involved with maintenance of intestinal epithelial integrity. (Pediatr Res 52: 430-436, 2002) Abbreviations Q, glutamine MS, methionine sulfoximine GS, glutamine synthetase TPN, total parenteral nutrition VLBW, very low birthweight H&E, hematoxylin and eosin TEM, transmission electron microscopy Previous studies have found that glutamine supplementation significantly decreases morbidity among critically ill patients. Adult bone marrow transplant recipients who received glutamine i.v. had significant decreases in length of hospital stay, hospital-acquired sepsis, and hospital costs (1, 2) . Studies in VLBW infants found that glutamine supplementation resulted in decreased morbidity and hospital costs (3) (4) (5) . Additionally, studies in rodents found that glutamine supplementation provides protection against sepsis and subsequent distal organ damage (6, 7) . The mechanisms of how glutamine acts to promote these beneficial effects are not known. However, there is evidence that its effect on intestinal mucosal integrity may play a role. The addition of glutamine to TPN has been demonstrated to maintain the integrity of small intestinal mucosa, therefore, preventing the atrophy typically noted with TPN (8) . In a previous study of multiple animal species, administration of glutaminase decreased plasma glutamine levels to almost undetectable levels (9) . This resulted in mild villous atrophy, mucosal ulcerations, and intestinal necrosis.
In addition to the small intestine being a major site of utilization of glutamine derived from nonintestinal sources, there is evidence that the intestine also produces glutamine (10 -13). The activity of GS increases just before weaning in the rat (11) . The role of de novo synthesized glutamine in the small intestine is poorly understood. Studies using immunofluorescence labeling and in situ hybridization, designed to determine the localization of GS in small intestine, established that intestinal glutamine production primarily occurs in the crypt, a region of rapid cell proliferation (10) . Studies using IEC-6 cells have demonstrated that inhibition of GS with MS, an inhibitor of GS (14) , causes a significant decrease in proliferation that requires supraphysiologic concentrations of exogenous glutamine for reversal (15) . Inhibition of GS in Caco-2 cells grown in transwell cultures results in decreased transepithelial resistance, opening of intercellular junctions, and decreased microvilli seen on TEM (16) .
In this study we used light microscopy and TEM to determine the effects of both dietary and endogenously produced glutamine on small intestinal morphology. The hypothesis is that deprivation of dietary glutamine leads to intestinal pathologic changes that can be exacerbated by MS, an inhibitor of endogenous glutamine synthesis (14) .
METHODS
The University of Florida Institutional Animal Care and Use Committee approved the following study.
Animal model. Thirty Sprague-Dawley (Zivic Miller Laboratories, Zelienople, PA, U.S.A.) infant rats were randomly assigned to four artificial feeding groups with six to seven rats per group. A mother-reared group (n ϭ 3) was used as a reference. Artificial feeding using the rat infant "pup in the cup" model began on d 7 of life through feeding tubes constructed from 14-cm sections of polyethylene tubing that were inserted into the stomach, as described by Phillips et al. (17) . This is a commonly used model in studies of developmental nutrition when it is important to manipulate nutritional composition in the absence of maternal feedings. The gastrostomy placement was performed under methoxyflurane anesthesia. Timer-controlled syringe pumps were connected to the feeding tubes and were set to feed the rats for the first 20 min of every hour at a weight-dependent flow rate. After a 1-to 2-d acclimation period during which they were fed with rat milk substitute (18) , the protein component was changed from casein and whey to a 10% Travasol amino acid solution, which was infused at a dose of 5 g/kg per day. This amino acid solution does not contain glutamine. This intake represents protein deprivation in these rats, that otherwise would require 30 to 40 g/kg per day for normal growth (18) . All the artificially fed groups received the same quantity of fat and carbohydrates. These pups were protein-deprived to partially mimic nutritional conditions in the Neonatal Intensive Care Unit, where VLBW infants are frequently not enterally fed for days to weeks and have their TPN amino acids slowly advanced over the first 1-2 wk of life.
MS, an irreversible GS inhibitor (14) , was added to the Travasol-containing rat milk substitute at a concentration of 1 mM to inhibit the endogenous de novo synthesis of glutamine in the gastrointestinal tract. The glutamine and MS in the four treatment groups was manipulated by adding 2% glutamine (wt/vol or 4 g/kg per day) (Qϩ group), adding MS (MSϩ group), adding MS and glutamine (MSϩQϩ group), and not adding either (MSϪQϪ group) to the formula. At the end of the 4-d treatment period, the rat pups were euthanized with an overdose of sodium pentobarbital. The small intestine was removed and separated into three parts-the ileum, jejunum, and duodenum-and fixed for 24 h in 10% neutral buffered formalin.
Light microscopy. We focused the microscopy studies on the ileum because this is a region that is most highly susceptible to certain pathologic changes in VLBW infants (e.g. necrotizing enterocolitis and nonnecrotizing enterocolitisrelated perforations). Furthermore, pilot evaluations of the duodenum and jejunum did not suggest major differences. Formalin-fixed ileum samples were embedded in paraffin; 6-m sections were cut using a 2030 Reichert-Jung paraffin microtome (Nusslock, Germany). The sections were then stained with a routine H&E stain (19) . Villus height and width were measured using a Nikon microscope (Universal Imaging Corp., Westchester, PA, U.S.A.) with an ocular micrometer without the examiner knowing the group assignment. The epithelial layer was measured at three points: two in the middle and one at the tip of the villus. This was done to assure the villus was not obliquely cut. Villus height was calculated by first measuring from the tip of the villus to the base of the tunica muscularis. Next, measurements were taken from the base of the villus to the base of the tunica muscularis on both sides of the villus; these values were then averaged. The averaged value from the bottom of the villus to the base of the tunica muscularis was then subtracted from the first measurement, thus giving the true villus height. Approximately 5 to 10 villi were measured for each H&E-stained section; each rat had three to four stained sections (15-40 villi per rat). Villus height and corresponding villus width data were combined to analyze villus height-to-width ratios. Lastly, villus density was determined by measuring the length (in micrometers) of parts of the bowel followed by counting the number of villi within that length. The number of villi was then divided by a unit length of intestine, giving a measurement of villi per micrometer.
Transmission electron microscopy. One-to two-centimeter sections of the ileum from three to five representative rats from each treatment group were dissected and placed in chilled 2% glutaraldehyde/0.1 M sodium cacodylate fixative. After dehydration and embedding in araldite epoxy resin, 1-m sections were made using glass knives on a Reichert Ultracut S ultramicrotome, stained with 1% toluidine blue in 1% sodium borate (20) , and examined with a light microscope. Target areas were selected for ultrastructural observations, and ultrathin sections (approximately 80 nm in thickness) were cut using a diamond knife and stained with saturated uranyl acetate and Reynold's lead citrate. Sections were viewed on a Hitachi H7000 TEM (Hitachi Software Engineering, Yokohama, Japan). General appearance and frequency of the microvilli were determined. The apical surfaces, frequency of junctional complexes, intercellular spaces, and cytoskeletal elements (terminal web and actin core of microvilli) were analyzed.
Statistical analysis. Sigmastat statistical software (SPSS Inc., Chicago, IL, U.S.A.) was used to analyze villus measurements. Villus height and villus height-to-width ratios were analyzed using an ANOVA to determine whether a significant 431 difference was present among all treatment groups. Additionally, Bonferroni t tests were performed for pairwise comparison of villus height, villus height-to-width ratios, and villus density among treatment groups.
RESULTS

Animals
Mortality in the individual groups was as follows: MSϪQϪ, two of six died (33%); MSϪQϩ, one of six died (16.7%); MSϩQϩ, two of six died (33.3%); MSϩQϪ, two of seven died (28.5%); and mother-reared, zero of three died (0%). The motherreared animals gained 33% weight during the course of the study, whereas the artificially reared rats lost 13% without a difference in weight loss among the various artificially reared rat groups.
Morphology and Epithelial Integrity
Light microscopy. An ANOVA performed on the villus height data shown in Figure 1A revealed statistically significant differences among the various treatment groups (p Յ 0.001). Individual contrasts using a t test with Bonferroni correction revealed that pups treated with MS, the GS inhibitor, and receiving no glutamine in their diet (MSϩQϪ) had significantly shorter (p ϭ 0.02) villus height in comparison with glutamine-supplemented pups (MSϪQϩ). Similarly, individual contrasts performed between mother-reared pups and each of the artificially reared treatment groups revealed that the mother-reared pups had significantly longer villi (p Ͻ 0.02).
An ANOVA of the villus height-to-width ratios (Fig. 1B ) also revealed a significant difference among all five groups (p ϭ 0.002). Individual contrasts of villus height-to-width ratios revealed the glutamine-supplemented (MSϪQϩ) group had a significantly larger ratio than the MS-treated group (MSϩQϪ; p ϭ 0.029). In addition, the mother-reared infant rats had a significantly larger villus height-to-width ratio than MSϪQϪ and MSϩQϪ rat pups (p Ͻ 0.05).
Additionally, ANOVA of villus density (villi per micrometer; Fig. 1C ) revealed a significant difference among the treatment groups (p Ͻ 0.001). Individual contrasts of villus density revealed the glutamine-supplemented group (MSϪQϩ) had significantly greater villus density than the group that was given MS and not supplemented with glutamine (MSϩQϪ; p Ͻ 0.001). Similarly the MSϪQϪ group also had significantly greater villus density than MSϩQϪ group (p Ͻ 0.001). Furthermore, the mother-reared group had significantly greater villus density than both the MSϩQϩ group and the MSϩQϪ group.
Representative photos of H&E-stained sections are shown in Figure 2 . These show the effects of dietary glutamine deprivation in the presence or absence of MS. The villus morphology corresponds to the graphs in Figure 1 . From these sections it is readily seen that the control group was the only group with fat globules in the epithelial cells, an effect we frequently see in normal, mother-fed rats. In addition to the villus blunting described by Figure 1 , it is evident from these photos that the intervillus distance appears greatest in the animals treated with MS (Fig. 2, C and D) . Figure 3 shows representative micrographs from the MSϪQϩ and MSϩQϪ groups, respectively. Figure 3B reveals uneven and deteriorating microvilli that are sloughing in the MSϩQϪ group. In addition to the microvillus sloughing, lack of actin cores, which normally are present within the microvilli, were observed in this group. Similar findings were found in the MSϩQϩ group (not shown). The lack of actin core in the microvilli was more pronounced in the MSϩQϪ group (denoted by arrow LAC in Fig. 3B ) than in the MSϩQϩ group. In fact, most microvilli of the MSϩQϪ group tended to be flexible, making the entire length difficult to observe. The flexible nature of these microvilli corresponds to their lack of actin cores. The terminal web was also significantly less noticeable in the MSϩQϪ group in comparison with the MSϪQϪ, MSϪQϩ, and mother-reared rat pups. Furthermore, cell death, deteriorating intercellular junctions (denoted by arrow DIJ in Fig. 3B) , splitting between cells, and in some 
Transmission electron microscopy.
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cases numerous large intercellular spaces were also noted among the rats that received MS. Comparison of all five groups' tissue sections revealed less-developed junctional complexes in the MSϩQϪ and MSϩQϩ treatment groups. In contrast, the tissue sections from the MSϪQϩ (Fig. 3A) , MSϪQϪ, and mother-reared groups appeared normal with tightly packed and even microvilli. The microvilli consisted of strong actin cores (denoted by arrow AC in Fig. 3A) extending downward from the apical surface and often anchoring to the terminal web. The epithelial cells in the MSϪQϩ group also displayed a higher degree of interdigitation than the other groups (denoted by arrow ID in Fig. 3A) . Numerous intact intercellular junctions, with noticeable zonula occludens, zonula adherens, and desmosomes, were present within the MSϪQϩ group (denoted by arrow TJ in Fig. 3A) , as well as the MSϪQϪ, and mother-reared groups (not shown). 
GLUTAMINE AND INTESTINE MORPHOLOGY
DISCUSSION
The significantly longer villi in the glutamine-supplemented group (MSϪQϩ) and the significantly shorter villi in pups subjected to endogenous glutamine synthesis inhibition (MSϩQϪ) support our hypothesis that both dietary and endogenously synthesized glutamine promotes intestinal integrity. The villus height-to-width ratios provided another measurement for overall gut health. The glutamine-supplemented group not treated with MS had the largest height-to-width ratio of all the artificially fed groups, and that ratio was the most comparable to that of the mother-reared group. Qualitative comparisons revealed that the MSϪQϩ group had the greatest villus density among all artificially reared treatment groups (Fig. 2B) . This implies that glutamine increases the surface area for absorption of nutrients within the small intestine of infant rats that are concomitantly deprived of dietary protein. This was further supported in the findings of villus density inasmuch as the MSϪQϩ group had significantly greater villi density than MSϩQϪ. Of note, rats receiving MS that also received supplemental glutamine (MSϩQϩ) only exhibited a minor "rescue" on the pathologic features of the small intestine caused by MS and glutamine deprivation (MSϩQϪ), suggesting that the benefits of dietary glutamine are optimized when enterocytes can normally synthesize glutamine. It is unknown whether or not this synergistic effect represents partitioning of exogenous and endogenous sources of glutamine carbon and nitrogen into downstream metabolites or whether the dietary supplementation that was given was insufficient.
The TEM results also supported the hypothesis. The glutamine-supplemented group (MSϪQϩ) displayed a high degree of intercellular interdigitation, which is associated with increased intercellular adhesion, and enhancement of the epithelial barrier. The deprivation of endogenous glutamine by administration of MS resulted in the breakdown of the epithelial barrier. Among the two treatment groups that received MS, intercellular junctional complexes were less prevalent than those observed in the glutamine-supplemented, control, and mother-reared groups. Because the epithelial cells are more tightly attached at this junctional region than anywhere else on the cellular surface, a lack of these tight junctions could have significant detrimental effects on the integrity of the gut. The presence of large intercellular spaces, apparent splitting between epithelial cells, and cell death within the MSϩQϪ and MSϩQϩ groups also supported our hypothesis that endogenous glutamine is important for the maintenance of the gut integrity. ID) . The MSϪQϩ group also had notable tight junctions (denoted by arrow TJ) and other junctional complexes. In addition, the microvilli in the MSϪQϩ group had prominent actin cores (denoted by arrow AC). The MSϩQϪ group displayed microvilli deteriorating and sloughing off; microvilli remaining exhibited a lack of actin cores (denoted by arrow LAC). The MSϩQϪ group also showed evidence of cells pulling apart or deteriorating intercellular junctions (denoted by arrow DIJ). Approximate magnification of images is ϫ20,000. Scale bars in each picture represent 1 m.
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The endogenously glutamine-deprived infant rats also displayed significant degeneration of the apical surface including sloughing of microvilli. As a result, few microvilli remained on any given epithelial cell. Furthermore, these same infant rats also lacked the presence of distinguishable actin cores within the microvilli (Fig. 3B) . Typically an actin core extends longitudinally down the middle of the microvillus and is anchored to the terminal web. This type of ultrastructure was not noted in these rats' tissue. Lastly, it was also difficult to discern the presence of terminal webs in the intestinal epithelial tissue of the MSϩQϪ and MSϩQϩ rats. Because the terminal web is connected to the zonula adherens, a component of the junctional complex, the lack of terminal webs correlates to the infrequency of intercellular junctional complexes. Moreover, the lack of actin cores among the few remaining microvilli correlates to the infrequency of terminal webs as these actin cores are known to attach to the terminal web. Actin cores, terminal webs, and zonula adherens are all either composed of cytoplasmic filaments or connected to these filaments. As a result, the lack of actin cores in microvilli, degradation of the terminal web, and few junctional complexes among the endogenously glutamine-deprived rat pups suggest that glutamine could play a role in maintaining a healthy cytoskeleton within cells. Because the cytoskeleton is related to the junctional complex, the healthy cytoskeleton that may be promoted by glutamine could be one mode by which glutamine enhances healthy small intestinal integrity and morphology. In summary, these results demonstrate the importance of dietary glutamine in maintaining the integrity of the small intestinal surface in the setting of limited neonatal nutrition.
Although it is likely that these findings are specific to glutamine, it is also possible that supplementation with other nutrients (amino acids, nucleotides) could result in similar outcomes. As previously stated the glutamine supplementation was in addition to a glutamine-free amino acid solution the pups were receiving. This solution was used because it was a readily available source to provide an amino acid mixture that is free of glutamine. In this experiment there were no isonitrogenous controls to balance an equal amount of amino acid intake among each group. As a result, the beneficial findings, which we ascribe to glutamine, could possibly be related to increased amino acid intake rather than being specific to glutamine supplementation. However, the use of isonitrogenous controls presents a dilemma as to what amino acid or group of amino acids should be used. Most have their own potentially beneficial or adverse effects. Because of this, we chose to examine the effects of glutamine supplementation versus no glutamine, as would be the case in clinical practice.
Previous studies point to the likelihood that breakdown of the intestinal mucosal barrier results in translocation of bacteria into the bloodstream (21) (22) (23) . Evidence is accumulating that glutamine supplementation prevents mucosal breakdown and decreases intercellular hyperpermeability and subsequent translocation of bacteria (24 -31) . Cell culture studies from our laboratory have demonstrated that inhibition of endogenous glutamine synthesis decreases proliferation (15) and intercellular junctional integrity (examined at the TEM level) (16) . Further preliminary in vivo studies have demonstrated increased mortality and bacterial translocation with GS inhibition (32) .
The mechanism of protection provided by glutamine remains poorly understood. Because of the myriad of metabolic processes in which glutamine is involved, the mechanism is probably multifactorial. The importance of glutamine and glutamate to enterocytes for energy production has been established (33) (34) (35) . Glutamine also acts to stimulate crypt cell proliferation via mitogen-activated protein kinases (36, 37) and is antiapoptotic via its interaction with glutamine-tRNA synthase, which in turn interacts with apoptosis signal-regulating kinases (38) . Furthermore, the utilization of the amide-N of glutamine for nucleotides has also now been realized (35) . Recent studies suggest that the amide-N of glutamine is also important for incorporation into hexosamines (39 -41) . Hexosamines, as components of glycoproteins and amino sugars, are very important in maintaining absorptive (via glycosylated membrane digestive hydrolases) and gut barrier functions (via the surface mucin barrier and glycoproteins that form intercellular tight junctions). The fuzzy glycocalyx coat of the villi, consisting of a family of glycoproteins and proteoglycans (of which the hexosamines are a major carbohydrate component), protects the intestine from autodigestion by luminal enzymes and may also protect the rest of the body from bacterial invasion. The importance of glutamine for maintenance of the mucus and intercellular junctional barrier are supported by studies that have demonstrated the critical relationship between glutamine and the mucus lining of the small intestine in the rat (41) . These studies demonstrated that alanyl-glutaminesupplemented TPN resulted in significant increases in goblet cells, glucosamine synthetase activity, and OD of mucus gel lining the intestine. This was associated with a decrease in permeability to FITC dextran.
There remains controversy about the relative benefits of glutamine for maintenance of intestinal morphology. Buchman (42) has questioned whether glutamine is necessary for the preservation of normal intestinal morphology and function in humans. The current study does not address this question in humans, but does provide information that demonstrates the detrimental effects of feeding a glutamine-free enteral diet and the inhibition of de novo synthesized glutamine in the infant rat intestine. The results described here support the hypothesis that both dietary and endogenously synthesized glutamine enhance morphologic indicators of intestinal integrity in infant rats. For both ethical and technical reasons, similar studies would be very difficult in humans, especially critically ill neonates, whose intestines are most likely to be susceptible to the effects of glutamine deprivation. It is also very difficult to accurately quantify villus and crypt dimensions and compare them from one patient to another in human punch biopsy material.
CONCLUSION
This study demonstrates that deprivation of dietary or endogenously synthesized glutamine results in a breakdown of the intestinal epithelium. We speculate that lack of glutamine in the diet and factors that decrease endogenous glutamine synthesis may result in deleterious consequences, which extend 435 GLUTAMINE AND INTESTINE MORPHOLOGY beyond the intestinal barrier, such as the development of systemic inflammatory response and alterations of the immune response.
